These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 3351480)

  • 1. Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus.
    O'Rourke K; Perryman LE; McGuire TC
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():667-74. PubMed ID: 3351480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine infectious anemia virus (EIAV) humoral responses of recipient ponies and antigenic variation during persistent infection.
    Rwambo PM; Issel CJ; Adams WV; Hussain KA; Miller M; Montelaro RC
    Arch Virol; 1990; 111(3-4):199-212. PubMed ID: 2162160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; Montelaro RC
    J Virol; 1987 Oct; 61(10):2956-61. PubMed ID: 2442410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection.
    Salinovich O; Payne SL; Montelaro RC; Hussain KA; Issel CJ; Schnorr KL
    J Virol; 1986 Jan; 57(1):71-80. PubMed ID: 3001367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies.
    Grund CH; Lechman ER; Pezzuolo NA; Issel CJ; Montelaro RC
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():435-42. PubMed ID: 8601778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90.
    Hussain KA; Issel CJ; Schnorr KL; Rwambo PM; West M; Montelaro RC
    Arch Virol; 1988; 98(3-4):213-24. PubMed ID: 2450529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serologic response of horses to equine arteritis virus as determined by competitive enzyme-linked immunosorbent assays (c-ELISAs) to structural and non-structural viral proteins.
    Wagner HM; Balasuriya UB; James MacLachlan N
    Comp Immunol Microbiol Infect Dis; 2003 Jul; 26(4):251-60. PubMed ID: 12676125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies and PMBC from EIAV infected carrier horses recognize gp45 and p26 synthetic peptides.
    Soutullo A; García MI; Bailat A; Racca A; Tonarelli G; Malan Borel I
    Vet Immunol Immunopathol; 2005 Dec; 108(3-4):335-43. PubMed ID: 16105689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An enzyme-linked immunosorbent assay (ELISA) for measurement of antibodies against equine herpesvirus 2 in equine sera.
    Fu ZF; Denby L; Lien DH; Robinson AJ
    Acta Virol; 1987 Nov; 31(6):468-74. PubMed ID: 2894140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the major glycoproteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3 using monoclonal antibodies.
    Crabb BS; Allen GP; Studdert MJ
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2075-82. PubMed ID: 1716650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibodies in persistent borna disease virus infection: prophylactic effect of gp94-specific monoclonal antibodies in preventing encephalitis.
    Furrer E; Bilzer T; Stitz L; Planz O
    J Virol; 2001 Jan; 75(2):943-51. PubMed ID: 11134307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anaemia virus.
    Montelaro RC; Robey WG; West MD; Issel CJ; Fischinger PJ
    J Gen Virol; 1988 Jul; 69 ( Pt 7)():1711-7. PubMed ID: 2839603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay for detection of equine infectious anemia antibody to purified P26 viral protein.
    Shen DT; Gorham JR; McGuire TC
    Am J Vet Res; 1984 Aug; 45(8):1542-3. PubMed ID: 6089620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
    Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
    Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies of the proteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3: antibody response of the natural hosts.
    Crabb BS; Studdert MJ
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2033-41. PubMed ID: 2170572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to equine herpesvirus 1 infection in foals during the first year of life.
    Kendrick JW; Stevenson W
    J Reprod Fertil Suppl; 1979; (27):615-8. PubMed ID: 225497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anaemia virus.
    Perryman LE; O'Rourke KI; Mason PH; McGuire TC
    Immunology; 1990 Dec; 71(4):592-4. PubMed ID: 1703988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity in mice of human metapneumovirus with a truncated SH glycoprotein.
    Tedcastle AB; Fenwick F; Robinson MJ; Toms GL
    J Med Virol; 2014 Apr; 86(4):547-57. PubMed ID: 24009128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection.
    Hertig C; Pye AD; Hyatt AD; Davis SS; McWilliam SM; Heine HG; Walker PJ; Boyle DB
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():631-40. PubMed ID: 8627251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.